WGS
Healthcare Diagnostics & ResearchGeneDx Holdings Corp.
$73.09
+2.13 +3.00% today
Price History
Not enough data
Key Stats
Market Cap
2.18B
Avg Volume
721,725
EPS
-$3.63
52W High
$170.87
52W Low
$32.21
Div. Yield
0.0%
Analyst Ratings
Buy1
Str Buy
7
Buy
0
Hold
0
Sell
0
Str Sell
Valuation
Forward P/E
60.98
P/B Ratio
8.92
P/S Ratio
4.80
EV/EBITDA
-65.72
EV/Revenue
4.87
Margins
Gross Margin 69.4%
Operating Margin (15.2%)
Net Margin (23.4%)
EBITDA Margin (7.4%)
Growth & Returns
Revenue Growth (YoY)
11.4%
Return on Equity
(40.8%)
Return on Assets
(7.9%)
Liquidity & Leverage
Current Ratio
3.30
Quick Ratio
2.90
Debt / Equity
0.69
Total Cash
132.55M
Total Debt
167.40M
About
GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.
www.genedx.com